Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014–2015

Flannery, Brendan; Zimmerman, Richard K.; Gubareva, Larisa V.; Garten, Rebecca J.; Chung, Jessie R.; Nowalk, Mary Patricia; Jackson, Michael L.; Jackson, Lisa A.; Monto, Arnold S.; Ohmit, Suzanne E.; Belongia, Edward A.; McLean, Huong Q.; Gaglani, Manjusha; Piedra, Pedro A.; Mishin, Vasiliy P.; Chesnokov, Anton P.; Spencer, Sarah; Thaker, Swathi N.; Barnes, John R.; Foust, Angie; Sessions, Wendy; Xu, Xiyan; Katz, Jacqueline; Fry, Alicia M.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014–2015

Published Date:

May 06 2016

Source:

J Infect Dis. 214(7):1010-1019

Language:

English

[PDF-1.14 MB]

Details:

Alternative Title:

J Infect Dis

Personal Author:

Flannery, Brendan ; Zimmerman, Richard K. ; Gubareva, Larisa V. ; Garten, Rebecca J. ; Chung, Jessie R. ; ... More ▼

Description:

Background

During the 2014–15 US influenza season, expanded genetic characterization of circulating influenza A(H3N2) viruses was used to assess the impact of genetic variability of influenza A(H3N2) viruses on influenza vaccine effectiveness (VE).

Methods

A novel pyrosequencing assay was used to determine genetic group based on hemagglutinin (HA) gene sequences of influenza A(H3N2) viruses from patients enrolled US Flu Vaccine Effectiveness network sites. Vaccine effectiveness was estimated using a test-negative design comparing vaccination among patients infected with influenza A(H3N2) viruses and uninfected patients.

Results

Among 9710 enrollees, 1868 (19%) tested positive for influenza A(H3N2); genetic characterization of 1397 viruses showed 1134 (81%) belonged to one HA genetic group (3C.2a) of antigenically drifted H3N2 viruses. Effectiveness of 2014–15 influenza vaccination varied by A(H3N2) genetic group from 1% (95% confidence interval [CI], −14% to 14%) against illness caused by antigenically drifted A(H3N2) group 3C.2a viruses versus 44% (95% CI, 16% to 63%) against illness caused by vaccine-like A(H3N2) group 3C.3b viruses.

Conclusion

Effectiveness of 2014–15 influenza vaccination varied by genetic group of influenza A(H3N2) virus. Changes in hemagglutinin genes related to antigenic drift were associated with reduced vaccine effectiveness.

Subject:

[+]

Pubmed ID:

27190176

Pubmed Central ID:

PMC5812259

Document Type:

Journal Article

Funding:

UL1 RR024153/RR/NCRR NIH HHS/United States ; U01IP000473/ACL HHS/United States ; UL1 TR001857/TR/NCATS NIH HHS/United States ; UL1 TR000005/TR/NCATS NIH HHS/United States ; U01 IP000473/IP/NCIRD CDC HHS/United States ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	nihms940444f3b.gif	image/gif
	nihms940444f3b.jpg	image/jpeg
	NIHMS940444-supplement-Supplemental_tables.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
	nihms940444.nxml	text/xml
	nihms940444f1.gif	image/gif
	nihms940444f1.jpg	image/jpeg
	nihms940444f2.gif	image/gif
	nihms940444f2.jpg	image/jpeg
	nihms940444f3a.gif	image/gif
	nihms940444f3a.jpg	image/jpeg

No Related Documents.

You May Also Like:

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018

Personal Author:

Jorquera, Patricia A.; Mishin, Vasiliy P.; Chesnokov, Anton; Nguyen, Ha T.; Mann, Brian; Garten, Rebecca; Barnes, John; Hodges, Erin; De La Cruz, Juan; Xu, Xiyan; Katz, Jackie; Wentworth, David E.; Gubareva, Larisa V.;

Published Date:

February 25 2019

Source:

Sci Rep. 9

Description:

Influenza A(H3N2) viruses evade human immunity primarily by acquiring antigenic changes in the haemagglutinin (HA). HA receptor-binding features of contemporary A(H3N2) viruses hinder traditional antigenic characterization using haemagglutination inh...

File Type:

[PDF - 3.95 MB]
Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season

Personal Author:

Jackson, Michael L.; Chung, Jessie R.; Jackson, Lisa A.; Phillips, C. Hallie; Benoit, Joyce; Monto, Arnold S.; Martin, Emily T.; Belongia, Edward A.; McLean, Huong Q.; Gaglani, Manjusha; Murthy, Kempapura; Zimmerman, Richard; Nowalk, Mary P.; Fry, Alicia M.; Flannery, Brendan;

Published Date:

Aug 10 2017

Source:

N Engl J Med. 377(6):534-543.

Description:

BACKGROUNDThe A(H1N1)pdm09 virus strain used in the live attenuated influenza vaccine was changed for the 2015–2016 influenza season because of its lack of effectiveness in young children in 2013–2014. The Influenza Vaccine Effectiveness Network ...

File Type:

[PDF - 553.16 KB]
FluView : 2017-2018 influenza season week 46 ending November 18, 2017

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.

Published Date:

November 18, 2017

Series:

FluView : 2017-2018 Influenza Season ; Week 46

Description:

All data are preliminary and may change as more reports are received.During week 46 (November 12-18, 2017), influenza activity increased in the United States.• Viral Surveillance: The most frequently identified influenza virus type reported by publ...

File Type:

[PDF - 672.67 KB]
FluView : 2016-2017 influenza season week 42 ending October 22, 2016

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.

Published Date:

October 28, 2016

Series:

FluView : 2016-2017 Influenza Season ; Week 42

Description:

All data are preliminary and may change as more reports are received.During week 42 (October 16-22, 2016), influenza activity was low in the United States.• Viral Surveillance: The most frequently identified influenza virus type reported by public ...

File Type:

[PDF - 1.22 MB]
FluView : 2016-2017 influenza season week 10 ending March 11, 2017

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.

Published Date:

March 17, 2017

Series:

FluView : 2016-2017 Influenza Season ; Week 10

Description:

During week 10 (March 5-11, 2017), influenza activity decreased, but remained elevated in the United States.• Viral Surveillance: The most frequently identified influenza virus subtype reported by public health laboratories during week 10 was influ...

File Type:

[PDF - 1.50 MB]